The proposed European unitary patent system could come into force as early as this year, so it is important for patent owners to begin considering how they will make use of the new system, if at all. This article will explore some of the factors that organisations in the pharmaceutical sector should be considering in advance of the new system coming into effect.
Insights: Biotechnology & Pharmaceuticals
The two year milestone since the UK’s first lockdown has recently passed. Looking back over this period, the speed and efficacy of vaccines and therapeutics reaching the clinic has been remarkable. But how has innovation in response to the COVID-19 pandemic been reflected in patent filings?
Of course, throughout the pandemic the number of people to whom we owe our thanks are countless. But there are a number of British scientists in leadership positions whose contribution (and the contribution of their team) is particularly notable.
The World Intellectual Property Organization (WIPO) reported that the number of Patent Cooperation Treaty (PCT) international applications with at least one female inventor was 33.3% in 2021, although only 16.5% of all inventors were women.
In the UK alone, 367,000 people are diagnosed with cancer every year. This insight looks at how radiotherapy plans are devised and executed in a clinical setting, and at some of the companies filing patent applications in this area.
We are pleased to introduce our new newsletter, Sustainable Future: Exploring innovations for the Energy Transition and Circular Economy.
This week, we learned that questions relating to the use of post-filed data/evidence to support a technical effect will be referred to the Enlarged Board of Appeal.
In addition to patents, pharmaceuticals and biopharmaceutical companies may achieve drug exclusivity in Europe through SPCs and regulatory data protection. This can exclude competitors and maximise return on substantial research and development investment.
Enter your email address here to receive our monthly bulletin of IP news and developments.